| BOMAC RESEARCH LIMITED Patent applications |
| Patent application number | Title | Published |
|---|
| 20120070506 | Animal Treatment - The present invention relates to a composition for an animal within a particular weight range including at least one non-steroidal anti-inflammatory drug (NSAID) compound and at least one mussel extract characterised in that the therapeutic dose of NSAID compound in the composition is substantially less than the usual therapeutic dose. | 03-22-2012 |
| 20110311589 | COMPOSITIONS AND DOSAGE REGIMES COMPRISING A CLOSTRIDIAL VACCINE AND LEVAMISOLE - A composition and dosage regime including a vaccine and levamisole for the treatment of clostridial diseases and helminthiasis. New methods of administration relating to particular dosage regimes of such a composition are also claimed. | 12-22-2011 |
| 20110287081 | BOLUS - The present invention relates to a bolus for administration to a ruminant by deposition into its rumen, wherein the bolus has a construction including: a) a casing; b) a core inside the casing wherein the core is formed from at least two tablets; and, is characterised in that a permanently amorphous substance at least partially coats one or more of the tablet or tablets. A method of forming such a bolus is also claimed. | 11-24-2011 |
| 20110280923 | BOLUS DEVICES FOR THE DELIVERY OF ACTIVE AGENTS TO ANIMALS - A bolus for administration of a substance to an animal, the bolus including An external coating, and A core inside the external coating wherein the core is formed from a plurality of dosage media, wherein each dosage media contains a substance, the bolus characterised in that the dosage media are ordered within the bolus such that the amount of substance released by each dosage media is progressively more than the amount of substance released by the previous dosage media. | 11-17-2011 |
| 20100137389 | TOPICAL FORMULATION - The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy. | 06-03-2010 |
| 20100016248 | TABLET FORMULATION - The invention relates to a tablet formulated for administration to an animal to treat parasite infestation. The tablet includes at least one macrocyclic lactone compound with anthelmintic activity dissolved in at least one organic solvent and subsequently formulated into a tablet. The tablets produced have a high degree of stability when stored over time and also provide the animal with a dose of agent sufficient to be therapeutically effective. | 01-21-2010 |
